SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001698530-24-000098
Filing Date
2024-08-26
Accepted
2024-08-26 09:10:45
Documents
16
Period of Report
2024-08-20
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20240820.htm   iXBRL 8-K 36756
2 EX-3.1 certificateofamendmenttoch.htm EX-3.1 9443
3 EX-99.1 ex991pressrelease82624.htm EX-99.1 9409
7 exicureimage1a10.gif GRAPHIC 2794
  Complete submission text file 0001698530-24-000098.txt   194223

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20240820.xsd EX-101.SCH 1907
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20240820_lab.xml EX-101.LAB 22532
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20240820_pre.xml EX-101.PRE 13047
18 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20240820_htm.xml XML 2806
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 241237929
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)